ABBOTINDIA 29057.55 -84.65(-0.29%)
ADANIGREEN 1953.60 +23.60(1.22%)
ADANIPORTS 1424.75 -1.95(-0.14%)
AMBUJACEM 619.10 -3.65(-0.59%)
APOLLOHOSP 7026.85 +21.90(0.31%)
ASHOKLEY 242.90 +1.20(0.50%)
ASIANPAINT 3288.55 -24.20(-0.73%)
ASTRAL 1887.40 -21.15(-1.11%)
AUBANK 724.85 +5.60(0.78%)
AUROPHARMA 1549.80 -2.25(-0.14%)
AXISBANK 1231.30 -0.20(-0.02%)
BAJAJ-AUTO 11944.25 +256.55(2.20%)
BAJAJFINSV 1887.55 +39.05(2.11%)
BAJAJHLDNG 10807.20 +438.05(4.22%)
BAJFINANCE 7627.25 +263.50(3.58%)
BANDHANBNK 213.35 +5.60(2.70%)
BANKBARODA 240.40 +1.35(0.56%)
BERGEPAINT 619.25 -3.90(-0.63%)
BHARATFORG 1572.05 -23.20(-1.45%)
BHARTIARTL 1661.45 +26.05(1.59%)
BOSCHLTD 34394.00 -310.00(-0.89%)
BPCL 342.60 +0.50(0.15%)
BRITANNIA 6124.50 +9.25(0.15%)
CHOLAFIN 1588.00 +14.55(0.92%)
CIPLA 1671.15 +11.50(0.69%)
COLPAL 3636.55 -12.45(-0.34%)
CONCOR 941.00 -4.30(-0.45%)
CUMMINSIND 3798.05 -46.75(-1.22%)
DABUR 653.35 -7.05(-1.07%)
DIVISLAB 5463.40 +8.95(0.16%)
DMART 5280.00 +61.50(1.18%)
DRREDDY 6576.50 -54.35(-0.82%)
DLF 859.95 -0.55(-0.06%)
FEDERALBNK 185.90 +1.60(0.87%)
GAIL 220.45 +0.90(0.41%)
GODREJCP 1454.25 -1.95(-0.13%)
GODREJPROP 2855.45 +18.45(0.65%)
GRASIM 2723.50 -31.85(-1.16%)
HAVELLS 1994.80 -11.25(-0.56%)
HDFCAMC 4424.00 -1.60(-0.04%)
HDFCBANK 1693.55 +24.85(1.49%)
HDFCLIFE 699.30 -0.10(-0.01%)
HCLTECH 1819.95 +8.95(0.49%)
HINDALCO 686.00 +3.60(0.53%)
HINDUNILVR 2875.75 +2.30(0.08%)
ICICIBANK 1290.25 +21.85(1.72%)
ICICIGI 2140.00 +37.45(1.78%)
ICICIPRULI 758.05 +6.70(0.89%)
IDEA 12.89 -0.23(-1.75%)
IDFCFIRSTB 72.36 -0.91(-1.24%)
INDHOTEL 686.80 -5.00(-0.72%)
INDUSINDBK 1477.05 +9.60(0.65%)
INFY 1889.30 -63.35(-3.24%)
ITC 507.45 -4.65(-0.91%)
JSWSTEEL 954.80 -8.95(-0.93%)
JUBLFOOD 673.05 -2.05(-0.30%)
KOTAKBANK 1845.90 +13.70(0.75%)
LT 3731.55 +38.60(1.05%)
LTTS 5728.50 +21.45(0.38%)
LUPIN 2253.65 -16.95(-0.75%)
M&M 2799.10 +10.90(0.39%)
MARICO 692.35 +0.60(0.09%)
MARUTI 12273.10 +25.50(0.21%)
MPHASIS 3011.80 -166.05(-5.23%)
MRF 133999.00 -1242.85(-0.92%)
MUTHOOTFIN 2020.00 -1.50(-0.07%)
NAUKRI 7747.60 -61.10(-0.78%)
NESTLEIND 2590.65 +44.95(1.77%)
NMDC 211.05 -3.55(-1.65%)
NTPC 414.30 -1.95(-0.47%)
ONGC 290.30 -4.25(-1.44%)
PAGEIND 42967.30 -458.25(-1.06%)
PEL 1079.50 -11.00(-1.01%)
PERSISTENT 5165.15 -190.95(-3.57%)
PGHH 16768.55 +138.50(0.83%)
PIDILITIND 3180.00 -89.90(-2.75%)
PIIND 4620.55 -71.15(-1.52%)
PNB 110.10 -0.70(-0.63%)
PNBHOUSING 1076.50 +24.25(2.30%)
POLYCAB 6698.00 -23.85(-0.35%)
POWERGRID 333.65 -3.00(-0.89%)
RELIANCE 2926.45 -18.15(-0.62%)
SBICARD 792.45 -7.65(-0.96%)
SBILIFE 1844.70 +22.40(1.23%)
SBIN 792.60 +9.55(1.22%)
SHREECEM 25342.90 -95.80(-0.38%)
SIEMENS 6719.15 -44.95(-0.66%)
SRF 2385.45 -44.90(-1.85%)
SUNPHARMA 1860.25 -5.65(-0.30%)
TATACONSUM 1207.20 -13.25(-1.09%)
TATACHEM 1030.50 -12.55(-1.20%)
TATAMOTORS 966.40 -8.60(-0.88%)
TATAPOWER 439.85 -5.20(-1.17%)
TATASTEEL 154.20 +0.80(0.52%)
TCS 4337.45 -166.20(-3.69%)
TECHM 1670.00 +21.35(1.29%)
TITAN 3721.80 -48.45(-1.29%)
TORNTPHARM 3375.00 -76.70(-2.22%)
TTML 89.76 -0.09(-0.10%)
ULTRACEMCO 11660.00 +10.55(0.09%)
UBL 2050.90 -34.10(-1.64%)
UPL 602.50 -7.75(-1.27%)
VEDL 449.65 +3.40(0.76%)
VOLTAS 1890.00 -13.15(-0.69%)
WIPRO 537.40 -14.25(-2.58%)
YESBANK 23.27 -0.13(-0.56%)
ZEEL 131.25 -1.80(-1.35%)
ZYDUSLIFE 1078.00 -32.35(-2.91%)

NEXUS SURGICAL AND MEDICARE ‘s Latest Q1 Report: Profit Up by 200% Year-on-Year

Image is loading

Highlights

  • The presented financial data is Standalone to provide a comprehensive overview of the company performance.
  • Sales over the Year and quarter: The company experienced a substantial growth of 65.88 % in the past year, substantial increase in net sales/revenue by 194.31 %.
  • Profit over the Year and quarter: Significant improvement in profitability for NEXUS SURGICAL AND MEDICARE LIMITED. Notable increase of 233.33 % in net profit Year to Year, NEXUS SURGICAL AND MEDICARE LIMITED’s profitability increased by 55.17 % in this quarter.
  • EPS over the Year and quarter: EPS increased by 220.00 % Year to Year. EPS increased by 45.45 % in previous quarter. Positive impact on shareholders.

The comprehensive analytics outlining the performance and outlook of NEXUS SURGICAL AND MEDICARE LIMITED‘s stock. This analysis encompasses various metrics including stock performance, investor sentiment, market trends, future outlook, risk factors, investment opportunities, long-term strategy, dividend policy, analyst insights, and the overall risk-reward profile. These insights aim to provide investors with a holistic understanding of the company”s stock, enabling informed decision-making and strategic investment planning.

Metrics Previous Year Previous Quarter Current Quarter Quarter to Quarter Difference Year to Year Difference
Sales Rs. 1.061 Cr Rs. 0.598 Cr Rs. 1.76 Cr + 194.31 % + 65.88 %
Expenses Rs. 1.03 Cr Rs. 0.51 Cr Rs. 1.64 Cr + 221.57 % + 59.22 %
Operating Profit Rs. 0.03 Cr Rs. 0.09 Cr Rs. 0.12 Cr + 33.33 % + 300 %
OPM % 2.83 % 15.05 % 6.82 % -8.23 % + 3.99 %
Other Income Rs. 0.008 Cr Rs. -0.005 Cr Rs. 0 Cr 0 % 0 %
Interest Rs. 0 Cr Rs. 0 Cr Rs. 0 Cr 0 % 0 %
Depreciation Rs. 0 Cr Rs. 0 Cr Rs. 0 Cr 0 % 0 %
Profit before tax Rs. 0.04 Cr Rs. 0.09 Cr Rs. 0.12 Cr + 33.33 % + 200 %
Tax % 25 % 30.12 % 25 % -5.12 % + 0 %
Net Profit Rs. 0.03 Cr Rs. 0.06 Cr Rs. 0.09 Cr + 50 % + 200 %
EPS in Rs Rs. 0.05 Rs. 0.11 Rs. 0.16 + 45.45 % + 220 %


Today, we’re looking at NEXUS SURGICAL AND MEDICARE LIMITED’s financial performance for the Q1(Jun 2024).Starting with the top line, the company reported a robust year-over-year sales growth of 65.88 %. However, it did see a marginal increase of 194.31 % from the previous quarter. Expenses ticked up slightly by 221.57 % quarter-on-quarter, aligning with the annual rise of 59.22 %. Operating profit, while up 300 % compared to last year, faced a quarter-on-quarter increase of 33.33 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 3.99 %, but a shrinkage of -8.23 % sequentially. Profit before tax grew annually by 200 % but saw an increase from the preceding quarter by 33.33 %.
Tax expenses as a percentage of profits increased slightly by 0 % compared to last year, with a more notable quarter-on-quarter decrease of -5.12 %. Net profit rose by 200 % year-on-year but experienced a 50 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 220 % but a quarterly rise of 45.45 %. In summary, NEXUS SURGICAL AND MEDICARE LIMITED’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.

Metrics Previous Year Previous Quarter Current Quarter Quarter to Quarter Difference Year to Year Difference
Sales Rs. 1.061 Cr Rs. 0.598 Cr Rs. 1.76 Cr + 194.31 % + 65.88 %
Expenses Rs. 1.03 Cr Rs. 0.51 Cr Rs. 1.64 Cr + 221.57 % + 59.22 %
Operating Profit Rs. 0.03 Cr Rs. 0.09 Cr Rs. 0.12 Cr + 33.33 % + 300 %
Net Profit Rs. 0.03 Cr Rs. 0.06 Cr Rs. 0.09 Cr + 50 % + 200 %
EPS in Rs Rs. 0.05 Rs. 0.11 Rs. 0.16 + 45.45 % + 220 %


In reviewing NEXUS SURGICAL AND MEDICARE LIMITED’s 2024(Q1) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 65.88 % year-on-year growth, however, there was a minor increase of 194.31 % from the previous quarter. Expenses rose by 59.22 % compared to the previous year, with a 221.57 % increase quarter-on-quarter. Operating Profit surged by 300 % annually, and saw a 33.33 % increase from the last quarter.
Net Profit showed yearly increase of 200 %, and experienced a 50 % increase from the previous quarter. Earnings Per Share (EPS) rose by 220 % annually, however rose by 45.45 % compared to the last quarter. In essence, while NEXUS SURGICAL AND MEDICARE LIMITED exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.

Join our telegram for more updates

Stay Updated with Our YouTube Videos

Related Post